Evidence map›Paper›PMID 31406660›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2019

Targeted Drug Delivery in Plants: Enzyme-Responsive Lignin Nanocarriers for the Curative Treatment of the Worldwide Grapevine Trunk Disease Esca.

Jochen Fischer, Sebastian J Beckers, Doungporn Yiamsawas, Eckhard Thines, Katharina Landfester, Frederik R Wurm

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Multifunctional lignin-based nanocomposites and nanohybrids.Green chemistry : an international journal and green chemistry resource : GC · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jochen FischerIBWF gGmbH Institute for Biotechnology and Drug Research Erwin-Schrödinger-Str. 56 67663 Kaiserslautern Germany.
Sebastian J BeckersMax-Planck-Institut für Polymerforschung Ackermannweg 10 55128 Mainz Germany.
Doungporn YiamsawasMax-Planck-Institut für Polymerforschung Ackermannweg 10 55128 Mainz Germany.
Eckhard ThinesIBWF gGmbH Institute for Biotechnology and Drug Research Erwin-Schrödinger-Str. 56 67663 Kaiserslautern Germany.
Katharina LandfesterMax-Planck-Institut für Polymerforschung Ackermannweg 10 55128 Mainz Germany.
Frederik R WurmMax-Planck-Institut für Polymerforschung Ackermannweg 10 55128 Mainz Germany.ORCID https://orcid.org/0000-0002-6955-8489

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanocarrier (NC)-mediated drug delivery is widely researched in medicine but to date has not been used in agriculture. The first curative NC-based treatment of the worldwide occurring grapevine trunk disease Esca, with more than 2 billion infected plants causing a loss yearly of $1.5 billion, is presented. To date, only repetitive spraying of fungicides is used to reduce chances of infection. This long-term treatment against Esca uses minimal amounts of fungicide encapsulated in biobased and biodegradable lignin NCs. A single trunk injection of <10 mg fungicide results in curing of an infected plant. Only upon Esca infection, ligninolytic enzymes, secreted by the Esca-associated fungi, degrade the lignin NC to release the fungicide. The specific antifungal activity is confirmed in vitro and in planta (in

Indexed as

agriculturegrapevine trunk diseasesminiemulsionnanocarriersplant protection

Identifiers

PMID31406660
PMCPMC6685467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.